Race/Gender-Specific Densitometry Database Warning Endorsed By Panel
This article was originally published in The Gray Sheet
Executive Summary
Gender and ethnicity-specific databases used with bone densitometry/sonometry devices to assess fracture risk should include cautionary language that their relevance has not undergone sufficient clinical evaluation, FDA's Radiological Devices Panel agreed at a May 17 meeting in Rockville, Maryland.
You may also be interested in...
Bone Sonometry PMAs Need Supporting Data From Caucasian Females
Patient databases used in support of premarket approval of bone densitometry/sonometry devices in assessing fracture risk should consist of Caucasian females 20-29, according to an FDA final guidance.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.